CHINA PHARMA HOLDINGS, INC. Income (Loss) from Continuing Operations, Per Basic Share
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Income (Loss) from Continuing Operations, Per Basic Share of -$0.04 per share for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2016-11-14
- CHINA PHARMA HOLDINGS, INC. income (loss) from continuing operations, per basic share for the quarter ending 2016-09-30 was -$0.04, a 157.14% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. income (loss) from continuing operations, per basic share for the quarter ending 2016-06-30 was -$0.06, a 300.00% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. income (loss) from continuing operations, per basic share for the quarter ending 2016-03-31 was -$0.04.
- CHINA PHARMA HOLDINGS, INC. income (loss) from continuing operations, per basic share for the quarter ending 2015-09-30 was $0.07.
- CHINA PHARMA HOLDINGS, INC. income (loss) from continuing operations, per basic share for fiscal 2015 was -$0.35.
- CHINA PHARMA HOLDINGS, INC. income (loss) from continuing operations, per basic share for fiscal 2014 was -$0.91.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 6 month | Income (Loss) from Continuing Operations, Per Basic Share 9 month | Income (Loss) from Continuing Operations, Per Basic Share 12 month |
|---|---|---|---|---|
| 2016-09-30 | -$0.04 10-Q · filed 2016-11-14 | -$0.13 10-Q · filed 2016-11-14 | ||
| 2016-06-30 | -$0.06 10-Q · filed 2016-08-11 | -$0.09 10-Q · filed 2016-08-11 | ||
| 2016-03-31 | -$0.04 10-Q · filed 2016-05-16 | |||
| 2015-12-31 | -$0.35 10-K · filed 2016-03-30 | |||
| 2015-09-30 | $0.07 10-Q · filed 2016-11-14 | -$0.21 10-Q · filed 2016-11-14 | ||
| 2015-06-30 | $0.03 10-Q · filed 2016-08-11 | -$0.16 10-Q · filed 2016-08-11 | ||
| 2015-03-31 | -$0.09 10-Q · filed 2016-05-16 | |||
| 2014-12-31 | -$0.91 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |